Although most of human breast tumors are ERα positive and anti-ER hormonal therapy represents the major therapeutic approach [18,19,20], the treatment of triple-negative breast cancers remains a challenge and still lacks a definite cure [19,20,21,22]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.